UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 14.354

Sortiert nach

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S796-S797

2021

Link zum Volltext

Verfügbarkeit prüfen

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S794-S795

2021

Link zum Volltext

Verfügbarkeit prüfen

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S795-S795

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploring the use of circulating tumor DNA for mutational signature analysis

Lung cancer (Amsterdam, Netherlands), 2024-07, Vol.193, p.107844-107844, Article 107844

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC

Lung cancer (Amsterdam, Netherlands), 2024-07, Vol.193, p.107856, Article 107856

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.995-1006

2024

Link zum Volltext

Verfügbarkeit prüfen

Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations

Journal of thoracic oncology, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context

Academic radiology, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S27-S27

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches

Annals of oncology, 2022-09, Vol.33 (9), p.893-908

2022

Link zum Volltext

Verfügbarkeit prüfen

Video-assisted mediastinoscopic lymphadenectomy (VAMLA): Mature results for staging non–small cell lung cancer with normal mediastinum

The Journal of thoracic and cardiovascular surgery, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study

Clinical lung cancer, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis

Biochimica et biophysica acta. Molecular basis of disease, 2024-08, Vol.1870 (6), p.167234, Article 167234

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer

Journal of the Formosan Medical Association, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Journal of thoracic oncology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Non-small cell lung cancer: current treatment and future advances

Translational lung cancer research, 2016-06, Vol.5 (3), p.288-300

2016

Link zum Volltext

Verfügbarkeit prüfen

Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway

Biomedicine & pharmacotherapy, 2024-07, Vol.176, p.116832, Article 116832

2024

Link zum Volltext

Verfügbarkeit prüfen

A rare case of non-small cell lung cancer with progressive elevation of CA199 as its first manifestation

Asian journal of surgery, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.205-215

2021

Link zum Volltext

Verfügbarkeit prüfen

Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway

Biochemical pharmacology, 2024-08, Vol.226, p.116345-116345, Article 116345

2024

Link zum Volltext

Verfügbarkeit prüfen

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

Oncoimmunology, 2017-06, Vol.6 (6), p.e1320011-e1320011

2017

Link zum Volltext

Verfügbarkeit prüfen

Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer

Asian Pacific journal of cancer prevention : APJCP, 2021-06, Vol.22 (6), p.1949-1955

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non–small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

The Journal of thoracic and cardiovascular surgery, 2024-04

Lee, Jay M.

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

Biochemical pharmacology, 2024-03, p.116161-116161, Article 116161

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 14.354

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThoracic Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.961)
Mit Volltextzugriff
(13.277)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(12.546)
Life Sciences & Biomedicine
(12.365)
Nsclc
(9.721)
Oncology
(7.842)
Humans
(7.285)
Lung Cancer
(4.784)
Lung Neoplasms - Pathology
(3.657)
Female
(3.353)
Carcinoma, Non-Small-Cell Lung - Pathology
(3.318)
Male
(3.294)
Non-Small Cell Lung Cancer
(3.204)
Lung Neoplasms - Drug Therapy
(3.147)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3.095)
Middle Aged
(2.810)
Respiratory System
(2.654)
Aged
(2.644)
Lung Neoplasms - Genetics
(2.594)
Carcinoma, Non-Small-Cell Lung - Genetics
(2.532)
Non-Small Cell Lung Carcinoma
(2.424)
Tumors
(2.099)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(833)
Translational Lung Cancer Research
(569)
Journal Of Thoracic Disease
(508)
Journal Of Thoracic Oncology
(468)
Frontiers In Oncology
(436)
Clinical Lung Cancer
(372)
Cancers
(355)
Oncotarget
(293)
Anticancer Research
(196)
Oncotargets And Therapy
(188)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Exploring the use of circulating tumor DNA for mutational signature analysis

Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC

Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib

Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations

Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches

Video-assisted mediastinoscopic lymphadenectomy (VAMLA): Mature results for staging non–small cell lung cancer with normal mediastinum

Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study

Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis

Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer

Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Non-small cell lung cancer: current treatment and future advances

Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway

A rare case of non-small cell lung cancer with progressive elevation of CA199 as its first manifestation

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway

Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer

Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non–small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

Aktive Filter

Suchergebnisse filtern